Real-Time Monitoring of Results During First Year of Dutch Colorectal Cancer Screening Program and Optimization by Altering Fecal Immunochemical Test Cut-Off Levels

Gastroenterology

Volumn 152, Issue 4, 2017, Pages 767-775.e2

  Toes Zoutendijk, Esther ^a   van Leerdam, Monique E ^b   Dekker, Evelien ^c   van Hees, Frank ^a   Penning, Corine ^a   Nagtegaal, Iris ^d   van der Meulen, Miriam P ^a   van Vuuren, Anneke J ^a   Kuipers, Ernst J ^a   Bonfrer, Johannes M G ^b   Biermann, Katharina ^a   Thomeer, Maarten G J ^a   van Veldhuizen, Harriët ^a   Kroep, Sonja ^a   van Ballegooijen, Marjolein ^a   Meijer, Gerrit A ^b   de Koning, Harry J ^a   Spaander, Manon C W ^a   Lansdorp Vogelaar, Iris ^a   Schipper, D L ^e   Masclee, A A M ^e   Wiersma, T J ^e   Otte, J A ^e   van der Beek, A ^e   van Kemenade, F J ^e   Stoker, J ^e   den Heeten, G J ^e   de Graaf, E J R ^e   van Grevenstein, W M U ^e   Kluiters, Y C M ^e   Blankenstein, M A ^e   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e NONE

Author keywords

Advanced Neoplasia; Colon Cancer; Early Detection; Population

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; CANCER RISK; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; CONSULTATION; CONTROLLED STUDY; FALSE POSITIVE RESULT; FECAL IMMUNOCHEMICAL TEST; FECES ANALYSIS; FEMALE; FOLLOW UP; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PATIENT MONITORING; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME MONITORING; ADENOMA; COLORECTAL NEOPLASMS; EARLY CANCER DIAGNOSIS; IMMUNOCHEMISTRY; NETHERLANDS; OCCULT BLOOD; PATIENT ATTITUDE; PROGRAM EVALUATION; STANDARDS; STATISTICS AND NUMERICAL DATA; UNNECESSARY PROCEDURE;

ADENOMA; AGED; COLONOSCOPY; COLORECTAL NEOPLASMS; EARLY DETECTION OF CANCER; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; IMMUNOCHEMISTRY; MALE; MIDDLE AGED; NETHERLANDS; OCCULT BLOOD; PATIENT ACCEPTANCE OF HEALTH CARE; PREDICTIVE VALUE OF TESTS; PROGRAM EVALUATION; UNNECESSARY PROCEDURES;

EID: 85014344473     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2016.11.022     Document Type: Article

References (31)

1. 1 Torre, L.A., Bray, F., Siegel, R.L., et al. Global cancer statistics, 2012. CA Cancer J Clin 65 (2015), 87–108.
2. 2 Schreuders, E.H., Ruco, A., Rabeneck, L., et al. Colorectal cancer screening: a global overview of existing programs. Gut 64 (2015), 1637–1649.
3. 3 Council of the European Union. Council recommendation of 2 December 2003 on cancer screening (2003/878/EC). Official Journal of the European Union 2003;327:34–38. Luxembourg, Luxembourg: Council of the European Union. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri-OJ:L:2003:327:0034:0038:EN: PDF. Accessed: July 29, 2015.
4. 4 Australian Institute of Health and Welfare (AIHW) 2015. National Bowel Cancer Screening Program: monitoring report 2013–14 Cancer series no. 94. Cat. no. CAN 92. Canberra: AIHW. Available from: http://www.aihw.gov.au/WorkArea/DownloadAsset.aspx?id=60129551419. Accessed: August 14, 2015.
5. 5 Canadian Task Force on Preventive Health Care. Recommendations on screening for colorectal cancer in primary care. CMAJ 188 (2016), 340–348.
6. 6 van der Steen, A., Knudsen, A.B., van Hees, F., et al. Optimal colorectal cancer screening in states' low-income, uninsured populations-the case of South Carolina. Health Serv Res 50 (2015), 768–789.
7. 7 Liles, E.G., Perrin, N., Rosales, A.G., et al. Change to FIT increased CRC screening rates: evaluation of a US screening outreach program. Am J Manag Care 18 (2012), 588–595.
8. 8 Gupta, S., Halm, E.A., Rockey, D.C., et al. Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: a randomized clinical trial. JAMA Intern Med 173 (2013), 1725–1732.
9. 9 Sung, J.J.Y., Ng, S.C., Chan, F.K.L., et al. An updated Asia Pacific Consensus Recommendations on colorectal cancer screening. Gut 64 (2015), 121–132.
10. 10 Hol, L., van Leerdam, M.E., van Ballegooijen, M., et al. Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical fecal occult blood testing and flexible sigmoidoscopy. Gut 59 (2010), 62–68.
11. 11 Hol, L., Wilschut, J.A., van Ballegooijen, M., et al. Screening for colorectal cancer: random comparison of guaiac and immunochemical fecal occult blood testing at different cut-off levels. Br J Cancer 100 (2009), 1103–1110.
12. 12 Stoop, E.M., de Haan, M.C., de Wijkerslooth, T.R., et al. Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol 13 (2012), 55–64.
13. 13 van Roon, A.H., Goede, S.L., van Ballegooijen, M., et al. Random comparison of repeated fecal immunochemical testing at different intervals for population-based colorectal cancer screening. Gut 62 (2013), 409–415.
14. 14 van Rossum, L.G., van Rijn, A.F., Laheij, R.J., et al. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population. Gastroenterology 135 (2008), 82–90.
15. 15 Wilschut, J.A., Habbema, J.D., van Leerdam, M.E., et al. Fecal occult blood testing when colonoscopy capacity is limited. J Natl Cancer Inst 103 (2011), 1741–1751.
16. 16 Casparie, M., Tiebosch, A.T., Burger, G., et al. Pathology databanking and biobanking in The Netherlands, a central role for PALGA, the nationwide histopathology and cytopathology data network and archive. Cell Oncol 29 (2007), 19–24.
17. 17 Dekker E, van Leerdam ME, Hazewinkel Y, et al. Nederlandse Richtlijn Coloscopie Surveillance. Nederlandse Vereniging van Maag-, Darm- en Leverartsen in samenwerking met Nederlandse Vereniging van Pathologie. 2013. Available from: http://www.mdl.nl/uploads/240/1308/Richtlijn_Coloscopie_Surveillance_definitief_2013.pdf. Accessed: July 30, 2015.
18. 18 Moss, S., Ancelle-Park, R., Brenner, H., International Agency for Research on Cancer. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First edition–evaluation and interpretation of screening outcomes. Endoscopy 44:Suppl 3 (2012), SE49–SE64.
19. 19 van Hees, F., Zauber, A.G., van Veldhuizen, H., et al. The value of models in informing resource allocation in colorectal cancer screening: the case of the Netherlands. Gut 64 (2015), 1985–1997.
20. 20 Giordano, L., von Karsa, L., Tomatis, M., et al. Mammographic screening programs in Europe: organization, coverage and participation. J Med Screen 19:Suppl 1 (2012), 72–82.
21. 21 Klabunde, C., Blom, J., Bulliard, J.L., et al. Participation rates for organized colorectal cancer screening programs: an international comparison. J Med Screen 22 (2015), 119–126.
22. 22 Viguier, J., Morere, J.F., Touboul, C., et al. Cancer screening in France: third edition of the EDIFICE survey. Eur J Cancer Prev 24:Suppl (2015), S68–S72.
23. 23 van Roon, A.H., Hol, L., Wilschut, J.A., et al. Advance notification letters increase adherence in colorectal cancer screening: a population-based randomized trial. Prev Med 52 (2011), 448–451.
24. 24 Symonds, E.L., Osborne, J.M., Cole, S.R., et al. Factors affecting fecal immunochemical test positive rates: demographic, pathological, behavioural and environmental variables. J Med Screen 22 (2015), 187–193.
25. 25 Faivre, J., Dancourt, V., Denis, B., et al. Comparison between a guaiac and three immunochemical fecal occult blood tests in screening for colorectal cancer. Eur J Cancer 48 (2012), 2969–2976.
26. 26 Zubero, M.B., Arana-Arri, E., Pijoan, J.I., et al. Population-based colorectal cancer screening: comparison of two fecal occult blood test. Front Pharmacol, 4, 2014, 175.
27. 27 Grobbee, E.J., van der Vlught, M., Stroobants, A.J., et al. A randomised comparison of two faecal immunochemical tests in population-based colorectal cancer screening. Gut, 2016 http://dx.doi.org/10.1136/gutjnl-2016-311819.
28. 28 Moss, S., Mathews, C., Day, T.J., et al. Increased uptake and improved outcomes of bowel cancer screening with a faecal immunochemical test: results form a pilot study within the national screening programme in England. Gut, 2016 http://dx.doi.org/10.1136/gutjnl-2015-310691.
29. 29 Denis, B., Gendre, I., Perrin, P., Participation in four rounds of a French colorectal cancer screening program with guaiac fecal occult blood test: a population-based open cohort study. J Med Screen 22 (2015), 76–82.
30. 30 Wilson JMG, Glover JW, Jungner G. Principles and practice of screening for disease. World Health Organization, Public Health Paper. 1968;34.
31. 31 Levin, T.R., Jamieson, L., Burley, D.A., et al. Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev 33 (2011), 101–110.